ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Raised to $24.00
ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) had its target price lifted by Morgan Stanley from $20.00 to $24.00 in a research report sent to investors on Tuesday morning,Benzinga reports. Morgan Stanley currently has an equal weight rating on the biopharmaceutical company’s stock. A number of other research analysts have also issued reports on ACAD. Wall […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) had its target price lifted by Morgan Stanley from $20.00 to $24.00 in a research report sent to investors on Tuesday morning,Benzinga reports. Morgan Stanley currently has an equal weight rating on the biopharmaceutical company’s stock. A number of other research analysts have also issued reports on ACAD. Wall […]
